ENC-201-CED hPI
/ Encellin
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 12, 2026
Safety of ENC-201-CED ENCRT
(clinicaltrials.gov)
- P1 | N=10 | Active, not recruiting | Sponsor: Encellin | Recruiting ➔ Active, not recruiting | Trial completion date: Jun 2026 ➔ Oct 2026 | Trial primary completion date: Dec 2025 ➔ Jul 2026
Enrollment closed • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus
May 10, 2024
Safety of ENC-201-CED ENCRT
(clinicaltrials.gov)
- P1 | N=10 | Recruiting | Sponsor: Encellin
New P1 trial • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus
1 to 2
Of
2
Go to page
1